Correction: Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines Free

In this article (Cancer Epidemiol Biomarkers Prev 2013;22:146–9), which was published in the January 2013 issue of Cancer Epidemiology, Biomarkers & Prevention (1), the development study for the Tyrer-Cuzick model was incorrectly identified as the Mayo Clinic Benign Breast Disease cohort in the Introduction. The model is correctly identified below. The authors regret the error.

The model is a statistical model based in part on the data obtained from the International Breast Intervention Study (IBIS).